{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:39:42Z","timestamp":1789202382083,"version":"build-2803163510"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2014,4,11]],"date-time":"2014-04-11T00:00:00Z","timestamp":1397174400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s10875-014-0021-8","type":"journal-article","created":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T08:23:54Z","timestamp":1397118234000},"page":"132-138","source":"Crossref","is-referenced-by-count":30,"title":["Treatment of Spinal Cord Injury with Intravenous Immunoglobulin G: Preliminary Evidence and Future Perspectives"],"prefix":"10.1007","volume":"34","author":[{"given":"Apostolia","family":"Tzekou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Fehlings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,11]]},"reference":[{"key":"21_CR1","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1742-2094-9-224","volume":"9","author":"DH Nguyen","year":"2012","unstructured":"Nguyen DH, Cho N, Satkunendrarajah K, Austin JW, Wang J, Fehlings MG. Immunoglobulin G (IgG) attenuates neuroinflammation and improves neurobehavioral recovery after cervical spinal cord injury. J Neuroinflammation. 2012;9:224.","journal-title":"J Neuroinflammation"},{"issue":"24","key":"21_CR2","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/00007632-200112151-00002","volume":"26","author":"LH Sekhon","year":"2001","unstructured":"Sekhon LH, Fehlings MG. Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine (Phila Pa 1976). 2001;26(24):S2\u201312.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"6","key":"21_CR3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1503\/cmaj.121206","volume":"185","author":"JR Wilson","year":"2013","unstructured":"Wilson JR, Forgione N, Fehlings MG. Emerging therapies for acute traumatic spinal cord injury. CMAJ. 2013;185(6):485\u201392.","journal-title":"CMAJ"},{"issue":"1","key":"21_CR4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3171\/jns.1991.75.1.0015","volume":"75","author":"CH Tator","year":"1991","unstructured":"Tator CH, Fehlings MG. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg. 1991;75(1):15\u201326.","journal-title":"J Neurosurg"},{"key":"21_CR5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0079-6123(02)37016-X","volume":"137","author":"G Schwartz","year":"2002","unstructured":"Schwartz G, Fehlings MG. Secondary injury mechanisms of spinal cord trauma: a novel therapeutic approach for the management of secondary pathophysiology with the sodium channel blocker riluzole. Prog Brain Res. 2002;137:177\u201390.","journal-title":"Prog Brain Res"},{"issue":"3","key":"21_CR6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.nbd.2003.11.015","volume":"15","author":"C Profyris","year":"2004","unstructured":"Profyris C, Cheema SS, Zang D, Azari MF, Boyle K, Petratos S. Degenerative and regenerative mechanisms governing spinal cord injury. Neurobiol Dis. 2004;15(3):415\u201336.","journal-title":"Neurobiol Dis"},{"issue":"10","key":"21_CR7","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/35094583","volume":"2","author":"SM Allan","year":"2001","unstructured":"Allan SM, Rothwell NJ. Cytokines and acute neurodegeneration. Nat Rev Neurosci. 2001;2(10):734\u201344.","journal-title":"Nat Rev Neurosci"},{"key":"21_CR8","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1749-6632.1999.tb08017.x","volume":"890","author":"L Guth","year":"1999","unstructured":"Guth L, Zhang Z, Steward O. The unique histopathological responses of the injured spinal cord. Implications for neuroprotective therapy. Ann NY Acad Sci. 1999;890:366\u201384.","journal-title":"Ann N.Y Acad Sci"},{"issue":"4","key":"21_CR9","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0306-4522(97)00011-0","volume":"79","author":"Y Taoka","year":"1997","unstructured":"Taoka Y, Okajima K, Uchiba M, Murakami K, Kushimoto S, Johno M, et al. Role of neutrophils in spinal cord injury in the rat. Neuroscience. 1997;79(4):1177\u201382.","journal-title":"Neuroscience"},{"issue":"17","key":"21_CR10","doi-asserted-by":"crossref","first-page":"7526","DOI":"10.1523\/JNEUROSCI.22-17-07526.2002","volume":"22","author":"LJ Noble","year":"2002","unstructured":"Noble LJ, Donovan F, Igarashi T, Goussev S, Werb Z. Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. J Neurosci. 2002;22(17):7526\u201335.","journal-title":"J Neurosci"},{"issue":"1","key":"21_CR11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/exnr.1998.6785","volume":"151","author":"SL Carlson","year":"1998","unstructured":"Carlson SL, Parrish ME, Springer JE, Doty K, Dossett L. Acute inflammatory response in spinal cord following impact injury. Exp Neurol. 1998;151(1):77\u201388.","journal-title":"Exp Neurol"},{"issue":"Pt 12","key":"21_CR12","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1242\/jeb.203.12.1783","volume":"203","author":"A Leskovar","year":"2000","unstructured":"Leskovar A, Moriarty LJ, Turek JJ, Schoenlein IA, Borgens RB. The macrophage in acute neural injury: changes in cell numbers over time and levels of cytokine production in mammalian central and peripheral nervous systems. J Exp Biol. 2000;203(Pt 12):1783\u201395.","journal-title":"J Exp Biol"},{"issue":"1-2","key":"21_CR13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0169-328X(00)00253-9","volume":"85","author":"K Satake","year":"2000","unstructured":"Satake K, Matsuyama Y, Kamiya M, Kawakami H, Iwata H, Adachi K, et al. Nitric oxide via macrophage iNOS induces apoptosis following traumatic spinal cord injury. Brain Res Mol Brain Res. 2000;85(1-2):114\u201322.","journal-title":"Brain Res Mol Brain Res"},{"issue":"1-2","key":"21_CR14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0165-5728(00)00372-6","volume":"111","author":"JM Schwab","year":"2000","unstructured":"Schwab JM, Brechtel K, Nguyen TD, Schluesener HJ. Persistent accumulation of cyclooxygenase-1 (COX-1) expressing microglia\/macrophages and upregulation by endothelium following spinal cord injury. J Neuroimmunol. 2000;111(1-2):122\u201330.","journal-title":"J Neuroimmunol"},{"issue":"2","key":"21_CR15","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.expneurol.2007.06.009","volume":"209","author":"DJ Donnelly","year":"2008","unstructured":"Donnelly DJ, Popovich PG. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol. 2008;209(2):378\u201388.","journal-title":"Exp Neurol"},{"key":"21_CR16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0079-6123(02)37032-8","volume":"137","author":"S David","year":"2002","unstructured":"David S. Recruiting the immune response to promote long distance axon regeneration after spinal cord injury. Prog Brain Res. 2002;137:407\u201314.","journal-title":"Prog Brain Res"},{"issue":"43","key":"21_CR17","doi-asserted-by":"crossref","first-page":"13435","DOI":"10.1523\/JNEUROSCI.3257-09.2009","volume":"29","author":"KA Kigerl","year":"2009","unstructured":"Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci. 2009;29(43):13435\u201344.","journal-title":"J Neurosci"},{"issue":"7","key":"21_CR18","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1523\/JNEUROSCI.22-07-02690.2002","volume":"22","author":"TB Jones","year":"2002","unstructured":"Jones TB, Basso DM, Sodhi A, Pan JZ, Hart RP, MacCallum RC, et al. Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy. J Neurosci. 2002;22(7):2690\u2013700.","journal-title":"J Neurosci"},{"issue":"6","key":"21_CR19","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S1471-4914(01)01993-1","volume":"7","author":"M Schwartz","year":"2001","unstructured":"Schwartz M, Kipnis J. Protective autoimmunity: regulation and prospects for vaccination after brain and spinal cord injuries. Trends Mol Med. 2001;7(6):252\u20138.","journal-title":"Trends Mol Med"},{"issue":"5","key":"21_CR20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cnr.2006.09.007","volume":"6","author":"A Trivedi","year":"2006","unstructured":"Trivedi A, Olivas AD, Noble-Haeusslein LJ. Inflammation and spinal cord injury: infiltrating leukocytes as determinants of injury and repair processes. Clin Neurosci Res. 2006;6(5):283\u201392.","journal-title":"Clin Neurosci Res"},{"issue":"7","key":"21_CR21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/sj.sc.3101483","volume":"41","author":"ON Hausmann","year":"2003","unstructured":"Hausmann ON. Post-traumatic inflammation following spinal cord injury. Spinal Cord. 2003;41(7):369\u201378.","journal-title":"Spinal Cord"},{"key":"21_CR22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1742-2094-9-137","volume":"9","author":"FH Brennan","year":"2012","unstructured":"Brennan FH, Anderson AJ, Taylor SM, Woodruff TM, Ruitenberg MJ. Complement activation in the injured central nervous system: another dual-edged sword? J Neuroinflammation. 2012;9:137.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"21_CR23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1602\/neurorx.1.1.80","volume":"1","author":"ED Hall","year":"2004","unstructured":"Hall ED, Springer JE. Neuroprotection and acute spinal cord injury: a reappraisal. NeuroRx. 2004;1(1):80\u2013100.","journal-title":"NeuroRx"},{"issue":"3","key":"21_CR24","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.neuroscience.2008.08.021","volume":"158","author":"T Riegger","year":"2009","unstructured":"Riegger T, Conrad S, Schluesener HJ, Kaps HP, Badke A, Baron C, et al. Immune depression syndrome following human spinal cord injury (SCI): a pilot study. Neuroscience. 2009;158(3):1194\u20139.","journal-title":"Neuroscience"},{"issue":"Suppl 5","key":"21_CR25","doi-asserted-by":"crossref","first-page":"V18","DOI":"10.1007\/s00415-006-5003-1","volume":"253","author":"M Stangel","year":"2006","unstructured":"Stangel M, Pul R. Basic principles of intravenous immunoglobulin (IVIg) treatment. J Neurol. 2006;253 Suppl 5:V18\u201324.","journal-title":"J Neurol"},{"issue":"Suppl 1","key":"21_CR26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2249.2009.04024.x","volume":"158","author":"HP Hartung","year":"2009","unstructured":"Hartung HP, Mouthon L, Ahmed R, Jordan S, Laupland KB, Jolles S. Clinical applications of intravenous immunoglobulins (IVIg)\u2013beyond immunodeficiencies and neurology. Clin Exp Immunol. 2009;158 Suppl 1:23\u201333.","journal-title":"Clin Exp Immunol"},{"issue":"Suppl 1","key":"21_CR27","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2249.2009.04029.x","volume":"158","author":"S Jolles","year":"2009","unstructured":"Jolles S, Kaveri SV, Orange J. Intravenous immunoglobulins. Current understanding and future directions. Clin Exp Immunol. 2009;158 Suppl 1:68\u201370.","journal-title":"Clin Exp Immunol"},{"key":"21_CR28","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1196\/annals.1423.054","volume":"1110","author":"T El-Shanawany","year":"2007","unstructured":"El-Shanawany T, Jolles S. Intravenous immunoglobulin and autoimmune disease. Ann NY Acad Sci. 2007;1110:507\u201315.","journal-title":"Ann NY Acad Sci"},{"issue":"4","key":"21_CR29","doi-asserted-by":"crossref","first-page":"356","DOI":"10.7861\/clinmedicine.6-4-356","volume":"6","author":"T El-Shanawany","year":"2006","unstructured":"El-Shanawany T, Sewell WA, Misbah SA, Jolles S. Current clinical uses of intravenous immunoglobulin. Clin Med. 2006;6(4):356\u20139.","journal-title":"Clin Med"},{"issue":"1","key":"21_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2005.02834.x","volume":"142","author":"S Jolles","year":"2005","unstructured":"Jolles S, Sewell WA, Misbah SA. Clinical uses of intravenous immunoglobulin. Clin Exp Immunol. 2005;142(1):1\u201311.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"21_CR31","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.neuroscience.2008.07.015","volume":"158","author":"TV Arumugam","year":"2009","unstructured":"Arumugam TV, Woodruff TM, Lathia JD, Selvaraj PK, Mattson MP, Taylor SM. Neuroprotection in stroke by complement inhibition and immunoglobulin therapy. Neuroscience. 2009;158(3):1074\u201389.","journal-title":"Neuroscience"},{"issue":"35","key":"21_CR32","doi-asserted-by":"crossref","first-page":"14104","DOI":"10.1073\/pnas.0700506104","volume":"104","author":"TV Arumugam","year":"2007","unstructured":"Arumugam TV, Tang SC, Lathia JD, Cheng A, Mughal MR, Chigurupati S, et al. Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death. Proc Natl Acad Sci U S A. 2007;104(35):14104\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"21_CR33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000109932","volume":"5","author":"SP Soelberg","year":"2008","unstructured":"Soelberg SP. Intravenous polyclonal human immunoglobulins in multiple sclerosis. Neurodegener Dis. 2008;5(1):8\u201315.","journal-title":"Neurodegener Dis"},{"issue":"4","key":"21_CR34","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jocn.2008.04.024","volume":"16","author":"B Gok","year":"2009","unstructured":"Gok B, Sciubba DM, Okutan O, Beskonakli E, Palaoglu S, Erdamar H, et al. Immunomodulation of acute experimental spinal cord injury with human immunoglobulin G. J Clin Neurosci. 2009;16(4):549\u201353.","journal-title":"J Clin Neurosci"},{"issue":"1","key":"21_CR35","first-page":"38","volume":"10","author":"AS Rivlin","year":"1978","unstructured":"Rivlin AS, Tator CH. Effect of duration of acute spinal cord compression in a new acute cord injury model in the rat. Surg Neurol. 1978;10(1):38\u201343.","journal-title":"Surg Neurol"},{"issue":"3","key":"21_CR36","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1017\/S031716710004484X","volume":"10","author":"M Khan","year":"1983","unstructured":"Khan M, Griebel R. Acute spinal cord injury in the rat: comparison of three experimental techniques. Can J NeurolSci. 1983;10(3):161\u20135.","journal-title":"Can J Neurol.Sci"},{"issue":"1","key":"21_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/neu.1995.12.1","volume":"12","author":"DM Basso","year":"1995","unstructured":"Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma. 1995;12(1):1\u201321.","journal-title":"J Neurotrauma"},{"issue":"4","key":"21_CR38","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3171\/jns.1977.47.4.0577","volume":"47","author":"AS Rivlin","year":"1977","unstructured":"Rivlin AS, Tator CH. Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J Neurosurg. 1977;47(4):577\u201381.","journal-title":"J Neurosurg"},{"issue":"6","key":"21_CR39","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1046\/j.1365-2133.2003.05372.x","volume":"148","author":"S Jolles","year":"2003","unstructured":"Jolles S, Hughes J. Importance of trial design in studies using high-dose intravenous immunoglobulin. Br J Dermatol. 2003;148(6):1284\u20135.","journal-title":"Br J Dermatol"},{"issue":"4","key":"21_CR40","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1365-2567.2002.01545.x","volume":"107","author":"WA Sewell","year":"2002","unstructured":"Sewell WA, Jolles S. Immunomodulatory action of intravenous immunoglobulin. Immunology. 2002;107(4):387\u201393.","journal-title":"Immunology"},{"issue":"2","key":"21_CR41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2249.2009.04081.x","volume":"160","author":"S Aschermann","year":"2010","unstructured":"Aschermann S, Lux A, Baerenwaldt A, Biburger M, Nimmerjahn F. The other side of immunoglobulin G: suppressor of inflammation. Clin Exp Immunol. 2010;160(2):161\u20137.","journal-title":"Clin Exp Immunol"},{"key":"21_CR42","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1600-065X.2010.00910.x","volume":"236","author":"F Nimmerjahn","year":"2010","unstructured":"Nimmerjahn F, Ravetch JV. Antibody-mediated modulation of immune responses. Immunol Rev. 2010;236:265\u201375.","journal-title":"Immunol Rev"},{"issue":"Suppl 1","key":"21_CR43","doi-asserted-by":"crossref","first-page":"I1","DOI":"10.1007\/s00415-005-1102-7","volume":"252","author":"N Misra","year":"2005","unstructured":"Misra N, Bayry J, Ephrem A, Dasgupta S, Delignat S, Duong Van Huyen JP, et al. Intravenous immunoglobulin in neurological disorders: a mechanistic perspective. J Neurol. 2005;252 Suppl 1:I1\u20136.","journal-title":"J Neurol"},{"issue":"5874","key":"21_CR44","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1154315","volume":"320","author":"RM Anthony","year":"2008","unstructured":"Anthony RM, Nimmerjahn F, Ashline DJ, Reinhold VN, Paulson JC, Ravetch JV. Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science. 2008;320(5874):373\u20136.","journal-title":"Science"},{"issue":"5787","key":"21_CR45","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1126\/science.1129594","volume":"313","author":"Y Kaneko","year":"2006","unstructured":"Kaneko Y, Nimmerjahn F, Ravetch JV. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science. 2006;313(5787):670\u20133.","journal-title":"Science"},{"issue":"5503","key":"21_CR46","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1126\/science.291.5503.484","volume":"291","author":"A Samuelsson","year":"2001","unstructured":"Samuelsson A, Towers TL, Ravetch JV. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science. 2001;291(5503):484\u20136.","journal-title":"Science"},{"issue":"Suppl 6","key":"21_CR47","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1212\/WNL.59.12_suppl_6.S13","volume":"59","author":"MC Dalakas","year":"2002","unstructured":"Dalakas MC. Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies. Neurology. 2002;59 Suppl 6:S13\u201321.","journal-title":"Neurology"},{"issue":"16","key":"21_CR48","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1523\/JNEUROSCI.5343-03.2004","volume":"24","author":"D Gris","year":"2004","unstructured":"Gris D, Marsh DR, Oatway MA, Chen Y, Hamilton EF, Dekaban GA. Transient blockade of the CD11d\/CD18 integrin reduces secondary damage after spinal cord injury, improving sensory, autonomic, and motor function. J Neurosci. 2004;24(16):4043\u201351.","journal-title":"J Neurosci"},{"issue":"13","key":"21_CR49","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1182\/blood-2006-05-021568","volume":"108","author":"S Gunten von","year":"2006","unstructured":"von Gunten S, Schaub A, Vogel M, Stadler BM, Miescher S, Simon HU. Immunologic and functional evidence for anti-siglec-9 autoantibodies in intravenous immunoglobulin preparations. Blood. 2006;108(13):4255\u20139.","journal-title":"Blood"},{"key":"21_CR50","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-065X.1994.tb00855.x","volume":"139","author":"U Andersson","year":"1994","unstructured":"Andersson U, Bjork L, Skansen-Saphir U, Andersson J. Pooled human IgG modulates cytokine production in lymphocytes and monocytes. Immunol Rev. 1994;139:21\u201342.","journal-title":"Immunol Rev"},{"issue":"2","key":"21_CR51","first-page":"211","volume":"79","author":"UG Andersson","year":"1993","unstructured":"Andersson UG, Bjork L, Skansen-Saphir U, Andersson JP. Down-regulation of cytokine production and interleukin-2 receptor expression by pooled human IgG. Immunology. 1993;79(2):211\u20136.","journal-title":"Immunology"},{"issue":"13","key":"21_CR52","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1161\/CIRCULATIONAHA.105.546150","volume":"112","author":"V Gill","year":"2005","unstructured":"Gill V, Doig C, Knight D, Love E, Kubes P. Targeting adhesion molecules as a potential mechanism of action for intravenous immunoglobulin. Circulation. 2005;112(13):2031\u20139.","journal-title":"Circulation"},{"issue":"Pt 12","key":"21_CR53","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1093\/brain\/awh297","volume":"127","author":"BM Lapointe","year":"2004","unstructured":"Lapointe BM, Herx LM, Gill V, Metz LM, Kubes P. IVIg therapy in brain inflammation: etiology-dependent differential effects on leucocyte recruitment. Brain. 2004;127(Pt 12):2649\u201356.","journal-title":"Brain"},{"issue":"8","key":"21_CR54","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1089\/neu.2011.2190","volume":"29","author":"F Bao","year":"2012","unstructured":"Bao F, Omana V, Brown A, Weaver LC. The systemic inflammatory response after spinal cord injury in the rat is decreased by alpha4beta1 integrin blockade. J Neurotrauma. 2012;29(8):1626\u201337.","journal-title":"J Neurotrauma"},{"issue":"11","key":"21_CR55","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1182\/blood.V93.11.3624","volume":"93","author":"TL Vassilev","year":"1999","unstructured":"Vassilev TL, Kazatchkine MD, Duong Van Huyen JP, Mekrache M, Bonnin E, Mani JC, et al. Inhibition of cell adhesion by antibodies to Arg-Gly-Asp (RGD) in normal immunoglobulin for therapeutic use (intravenous immunoglobulin, IVIg). Blood. 1999;93(11):3624\u201331.","journal-title":"Blood"},{"issue":"7","key":"21_CR56","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.4049\/jimmunol.161.7.3781","volume":"161","author":"NK Prasad","year":"1998","unstructured":"Prasad NK, Papoff G, Zeuner A, Bonnin E, Kazatchkine MD, Ruberti G, et al. Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway. J Immunol. 1998;161(7):3781\u201390.","journal-title":"J Immunol"},{"key":"21_CR57","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.expneurol.2013.01.008","volume":"247","author":"AM Laliberte","year":"2013","unstructured":"Laliberte AM, Fehlings MG. The immunological response to spinal cord injury: helpful or harmful? Exp Neurol. 2013;247:282\u20135.","journal-title":"Exp Neurol"},{"key":"21_CR58","doi-asserted-by":"crossref","unstructured":"Saltzman JW, Battaglino R, Stott H, Morse LR. Neurotoxic or neuroprotective? current controversies in SCI-induced autoimmunity. Curr Phys Med Rehabil Rep. 2013;1(3):174\u20137 doi: 10.1007\/s40141-013-0021-2 .","DOI":"10.1007\/s40141-013-0021-2"},{"issue":"6","key":"21_CR59","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.2353\/ajpath.2010.100408","volume":"177","author":"PF Stahel","year":"2010","unstructured":"Stahel PF, Flierl MA. Targeted modulation of the neuroinflammatory response after spinal cord injury: the ongoing quest for the \u201choly grail\u201d. Am J Pathol. 2010;177(6):2685\u20137.","journal-title":"Am J Pathol"},{"issue":"7","key":"21_CR60","doi-asserted-by":"crossref","first-page":"464","DOI":"10.7326\/0003-4819-154-7-201104050-00004","volume":"154","author":"M Gousseff","year":"2011","unstructured":"Gousseff M, Arnaud L, Lambert M, Hot A, Hamidou M, Duhaut P, et al. The systemic capillary leak syndrome: a case series of 28 patients from a european registry. Ann Intern Med. 2011;154(7):464\u201371.","journal-title":"Ann Intern Med"},{"issue":"5","key":"21_CR61","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/jac\/dkr027","volume":"66","author":"T Saito","year":"2011","unstructured":"Saito T, Kimura S, Tateda K, Mori N, Hosono N, Hayakawa K, et al. Evidence of intravenous immunoglobulin as a critical supportive therapy against clostridium difficile toxin-mediated lethality in mice. J Antimicrob Chemother. 2011;66(5):1096\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"21_CR62","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/jnnp.57.Suppl.65","volume":"57","author":"BG Engelen van","year":"1994","unstructured":"van Engelen BG, Miller DJ, Pavelko KD, Hommes OR, Rodriguez M. Promotion of remyelination by polyclonal immunoglobulin in Theiler\u2019s virus-induced demyelination and in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1994;57:65\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"21_CR63","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/138161206775193118","volume":"12","author":"C Trebst","year":"2006","unstructured":"Trebst C, Stangel M. Promotion of remyelination by immunoglobulins: implications for the treatment of multiple sclerosis. Curr Pharm Des. 2006;12(2):241\u20139.","journal-title":"Curr Pharm Des"},{"issue":"Suppl 1","key":"21_CR64","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1007\/s10875-010-9403-8","volume":"30","author":"A Goebel","year":"2010","unstructured":"Goebel A. Immunoglobulin responsive chronic pain. J Clin Immunol. 2010;30 Suppl 1:S103\u20138.","journal-title":"J Clin Immunol"},{"issue":"10","key":"21_CR65","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/j.1526-4637.2012.01478.x","volume":"13","author":"S Jann","year":"2012","unstructured":"Jann S, Francia A, Fruguglietti ME, De Toni FL, Sterzi R. Efficacy and safety of intravenous immunoglobulin as adjuvant treatment for refractory neuropathic pain. Results of an open-label, multicenter study. Pain Med. 2012;13(10):1334\u201341.","journal-title":"Pain Med"},{"issue":"1","key":"21_CR66","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/jnnp.2008.149013","volume":"80","author":"S Jann","year":"2009","unstructured":"Jann S, Bramerio MA, Facchetti D, Sterzi R. Intravenous immunoglobulin is effective in patients with diabetes and with chronic inflammatory demyelinating polyneuropathy: long term follow-up. J Neurol Neurosurg Psychiatry. 2009;80(1):70\u20133.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"21_CR67","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/archneur.59.5.751","volume":"59","author":"KR Sharma","year":"2002","unstructured":"Sharma KR, Cross J, Ayyar DR, Martinez-Arizala A, Bradley WG. Diabetic demyelinating polyneuropathy responsive to intravenous immunoglobulin therapy. Arch Neurol. 2002;59(5):751\u20137.","journal-title":"Arch Neurol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-014-0021-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-014-0021-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-014-0021-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:55:54Z","timestamp":1689123354000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-014-0021-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,11]]},"references-count":67,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["21"],"URL":"https:\/\/doi.org\/10.1007\/s10875-014-0021-8","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,11]]}}}